CVS Health Reports First Quarter Results And Confirms 2018 Full Year Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CVS Health (CVS) PT Raised to $91 at RBC Capital; Technical Issues Weighing on Shares
May 3, 2018 8:39 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $91.00 (from $89.00) while maintaining a Outperform rating.
Analyst George Hill commented, "CVS reported Q1 results that beat our estimates and consensus, driven by stronger- than-expected results in the Pharmacy/LTC... More
CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views
May 2, 2018 6:58 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $1.48, $0.06 better than the analyst estimate of $1.42. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.79 billion.
GUIDANCE:
CVS Health sees FY2018 EPS of $6.87-$7.08, versus the... More
